Legal Representation
Attorney
Susan Neuberger Weller
USPTO Deadlines
Application History
44 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Apr 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Sep 8, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Sep 7, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Sep 7, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED |
Aug 28, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 28, 2023 | EXT5 | S | SOU EXTENSION 5 FILED |
Feb 16, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 14, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 14, 2023 | EXT4 | S | SOU EXTENSION 4 FILED |
Feb 14, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jan 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Aug 25, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 23, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 23, 2022 | EXT3 | S | SOU EXTENSION 3 FILED |
Aug 23, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED |
Feb 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 22, 2022 | EXT2 | S | SOU EXTENSION 2 FILED |
Feb 22, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED |
Jul 20, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jul 20, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jul 20, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jun 8, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 4, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jun 4, 2021 | EXT1 | S | SOU EXTENSION 1 FILED |
Jun 4, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED |
Mar 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jan 5, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jan 5, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Dec 16, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Dec 2, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Nov 23, 2020 | ALIE | A | ASSIGNED TO LIE |
Nov 23, 2020 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Apr 21, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Apr 21, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Apr 21, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Apr 21, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Apr 21, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN |
Apr 21, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
Apr 21, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Apr 20, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 6, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Feb 6, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005